Anbio Biotechnology Class A Ordinary Shares
NNNN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $244,020 | $830,252 | $830,252 | $577,000 |
| - Cash | $11,761 | $9,688 | $7,102 | $4,181 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $232,259 | $820,564 | $823,150 | $572,819 |
| Revenue | $8,185 | $6,712 | $23,545 | $4,428 |
| % Growth | 21.9% | -71.5% | 431.7% | – |
| Gross Profit | $5,885 | $3,361 | $12,564 | $2,542 |
| % Margin | 71.9% | 50.1% | 53.4% | 57.4% |
| EBITDA | $2,567 | $2,267 | $10,025 | $2,536 |
| % Margin | 31.4% | 33.8% | 42.6% | 57.3% |
| Net Income | $2,373 | $2,254 | $10,011 | $2,536 |
| % Margin | 29% | 33.6% | 42.5% | 57.3% |
| EPS Diluted | 0.056 | 0.012 | 0.07 | 0.025 |
| % Growth | 366.7% | -82.8% | 174% | – |
| Operating Cash Flow | $2,080 | $898 | $4,449 | $4,181 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | $2,080 | $898 | $4,449 | $4,181 |